Related Experiment Videos
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder.
Neuropsychiatric disease and treatment·2009
Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.
Journal of the American Academy of Child and Adolescent Psychiatry·2008
Critical assessment of the methylphenidate transdermal system.
Drugs of today (Barcelona, Spain : 1998)·2007
Effectiveness of a children's home and community-based services waiver program.
The Psychiatric quarterly·2007
Affective Neuroscience Personality Scales as Indicators of SSRI Treatment Response in Youths with Major Depressive Episodes: A Retrospective Cohort Study.
Journal of child and adolescent psychopharmacology·2026
Amantadine-Responsive, Benzodiazepine-Resistant Catatonia in an Adolescent With Autism Spectrum Disorder.
Journal of child and adolescent psychopharmacology·2026
Antipsychotic Use During Catatonia in Youth with Neurodevelopmental Disorders and Psychotic Symptoms: A 20-Patient Case Series.
Journal of child and adolescent psychopharmacology·2026
Utility of ADHD Medications in Children and Adolescents with Trauma-Related Presentations: A Systematic Scoping Review.
Journal of child and adolescent psychopharmacology·2026
Clozapine for Severe Treatment-Resistant Disruptive Behaviors in Youth with Autism Spectrum Disorder: A Prospective Real-World Interventional Study.
Journal of child and adolescent psychopharmacology·2026
Psychopathological Severity Across the Cognitive Continuum: A Comparative Study of Adolescents with Average Intelligence, Borderline Intellectual Functioning, and Intellectual Disability.
Journal of child and adolescent psychopharmacology·2026
Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.
Canadian journal of kidney health and disease·2026
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.
Therapeutic advances in neurological disorders·2026